Debate Over EU Finding That Pharmaceutical Firms Abusing Patent System
By David Cronin for Intellectual Property Watch BRUSSELS – Leading pharmaceutical companies are using the patent system to delay the entry of generic medicines onto the market, the European Commission has alleged, sparking a debate at a conference held here…
